Related references
Note: Only part of the references are listed.Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer
Ingiridur Anna Skirnisdottir et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Significance of Cell Cycle Regulatory Proteins as Malignant and Prognostic Biomarkers in Ovarian Epithelial Tumors
Yoon Hee Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
Richard G. Moore et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer
Timothy J. Duncan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
K. Huhtinen et al.
BRITISH JOURNAL OF CANCER (2009)
A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
Samuel C. Mok et al.
CANCER CELL (2009)
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2009)
A prognostic gene expression index in ovarian cancer - validation across different independent data sets
Carsten Denkert et al.
JOURNAL OF PATHOLOGY (2009)
Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples
Balazs Gyorffy et al.
PLOS ONE (2009)
The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving meta-analysis and prediction of prognosis
Andrew H. Sims et al.
BMC MEDICAL GENOMICS (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma
B. Gyoerffy et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Significance of E2F-1 overexpression in epithelial ovarian cancer
D. S. Suh et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel
Ahmed Ashour Ahmed et al.
CANCER CELL (2007)
Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas
Georgia Levidou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma
M. Haysam Khouja et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy
Isabelle Bedrosian et al.
CLINICAL CANCER RESEARCH (2007)
Methylation profile in benign, borderline and malignant ovarian tumors
K. F. Tam et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
A gynecologic oncology group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy
Kathleen M. Darcy et al.
CANCER RESEARCH (2007)
Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: A potential role for interleukin 7
Annechien J. A. Lambeck et al.
CLINICAL CANCER RESEARCH (2007)
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
Kenjiro Sawada et al.
CANCER RESEARCH (2007)
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer
S. Sillanpaa et al.
GYNECOLOGIC ONCOLOGY (2007)
Independent prognostic significance of cell cycle regulator proteins p16INK4a and pRb in advanced-stage ovarian carcinoma including optimally debulked patients:: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group
S. Kommoss et al.
BRITISH JOURNAL OF CANCER (2007)
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma
Lilach Kleinberg et al.
CANCER (2007)
Clinical relevance of E2F family members in ovarian cancer - An evaluation in a training set of 77 patients
Daniel Reimer et al.
CLINICAL CANCER RESEARCH (2007)
Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer
Lukas A. Hefler et al.
GYNECOLOGIC ONCOLOGY (2006)
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: A multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)
J. A. Green et al.
EUROPEAN JOURNAL OF CANCER (2006)
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study
J. M. Riedinger et al.
ANNALS OF ONCOLOGY (2006)
Evaluation of the prognostic value of cellular, inhibitor of apoptosis protein in epithelial ovarian cancer using automated quantitative protein analysis
Amanda Psyrri et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: A Gynecologic Oncology Group study
Angeles Alvarez Secord et al.
GYNECOLOGIC ONCOLOGY (2006)
Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma
DG Rosen et al.
CANCER (2006)
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer
AA Kamat et al.
CLINICAL CANCER RESEARCH (2006)
Cyclin-dependant kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer
A Schmider-Ross et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
BURCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study
M Thrall et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer
A Psyrri et al.
CLINICAL CANCER RESEARCH (2005)
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: A clinicopathologic study
H Brustmann
GYNECOLOGIC ONCOLOGY (2005)
The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma
A Gadducci et al.
GYNECOLOGIC ONCOLOGY (2004)
A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging
I Skírnisdóttir et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
Y Wang et al.
BRITISH JOURNAL OF CANCER (2004)
Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression
PL Torng et al.
GYNECOLOGIC ONCOLOGY (2004)
Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer
D Katsaros et al.
GYNECOLOGIC ONCOLOGY (2004)
Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer
A Bali et al.
CLINICAL CANCER RESEARCH (2004)
ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma
H Lassus et al.
GYNECOLOGIC ONCOLOGY (2004)
Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer
JS Nielsen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
Interferon-γ expression is an independent prognostic factor in ovarian cancer
C Marth et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
被撤回的出版物: The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study (Retracted Article. See vol 96, pg 1021, 2005)
EK Riener et al.
GYNECOLOGIC ONCOLOGY (2004)
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer
A Widschwendter et al.
GYNECOLOGIC ONCOLOGY (2004)
Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer
F Barbieri et al.
ONCOLOGY (2004)
Evaluation of gene expression measurements from commercial microarray platforms
PK Tan et al.
NUCLEIC ACIDS RESEARCH (2003)
P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens
J Plisiecka-Halasa et al.
ANNALS OF ONCOLOGY (2003)
Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis
C Cohen et al.
MODERN PATHOLOGY (2003)
Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer
K Milde-Langosch et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2003)
Human kallikrein 6 (hK6): A new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma
EP Diamandis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Reduced retinoblastoma gene protein to Ki-67 ratio is an adverse prognostic indicator for ovarian adenocarcinoma patients
AE Konstantinidou et al.
GYNECOLOGIC ONCOLOGY (2003)
Preoperative CA 125 levels: An independent prognostic factor for epithelial ovarian cancer
BC Cooper et al.
OBSTETRICS AND GYNECOLOGY (2002)
Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer
K Kudoh et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The combined evaluation of p27Kip1 and Ki-67 expression provides independent information on overall survival of ovarian carcinoma patients
P Korkolopoulou et al.
GYNECOLOGIC ONCOLOGY (2002)
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer:: a multifactorial analysis of TP53, p21, BAX and BCL-2
M Schuyer et al.
BRITISH JOURNAL OF CANCER (2001)
Implication of malignancy and prognosis of p27kip1, cyclin E, and Cdk2 expression in epithelial ovarian tumors
L Sui et al.
GYNECOLOGIC ONCOLOGY (2001)
The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer
A Gadducci et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2001)
P53, bcl-2, and bax:: Their relationship and effect on prognosis in early stage epithelial ovarian carcinoma
I Skirnisdóttir et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2001)
Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer
M Baekelandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Serum soluble Fas levels in ovarian cancer
L Hefler et al.
OBSTETRICS AND GYNECOLOGY (2000)
p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma
A Schmider et al.
GYNECOLOGIC ONCOLOGY (2000)
Share Paper
